Table 2. Clinical characteristics of PLWHA attending ART clinic at Hawassa University Comprehensive Specialized Hospital, SNNPR, Ethiopia, 2019 (n = 389).
| Clinical factors | Frequency and (%) |
|---|---|
| WHO clinical stages | |
| Stage I | 267 (68.6) |
| Stage II | 96 (24.7) |
| Stage III | 20 (5.1) |
| Stage IV | 6 (1.5) |
| Time since HIV diagnosis | |
| ≤1 year | 75 (19.3) |
| >1 year | 314 (80.7) |
| CD4 count | |
| <200 cells/ml | 11 (2.8) |
| 200–499 cells/ml | 119 (30.6) |
| ≥500 cells/ml | 259 (66.6) |
| ART drug Type | |
| EFV-based | 209 (53.7) |
| Non-EFV | 180 (46.3) |
| Presence of any comorbid chronic medical illness (DM, Ca, HTN or other) | |
| No | 283 (72.8) |
| Yes | 106 (27.2) |
Abbreviation: DM: Diabetes Mellitus, Ca: Cancer, HTN: Hypertension, ART: Antiretroviral Therapy, EFV: Efavirenz